NCT07014579

Brief Summary

The goal of this observational study is to learn if two specific heart electrical signal patterns can help in detecting the risk of dangerous heart rhythms in athletes, and to see if exercise-based tests can be used instead of invasive hospital procedures to record this electrical signals. The main questions it aims to answer are:

  1. 1.Can special ECG action potential duration markers (R2I2 and PERS) identify athletes who are at higher risk of sudden heart rhythm problems.
  2. 2.Can an exercise test give the same information as a non-invasive electrophysiology study.
  3. 3.ECG recordings during rest and exercise.
  4. 4.If they have an ICD or pacemaker, an ECG will be recorded during a non invasive stimulation.
  5. 5.A continuous 24 hour ECG.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

1.2 years

First QC Date

May 28, 2025

Last Update Submit

June 9, 2025

Conditions

Keywords

ULTIMATE-AthleteLifeMapR2I2PERSVentricular ArrhythmiaVentricular FibrillationSudden Cardiac Death

Outcome Measures

Primary Outcomes (1)

  • Change in Restitution Markers as Determined by R2I2 and PERS

    The primary outcome measure is assessment of changes in the regional restitution instability index and peak ECG restitution slope at various time points including, baseline, during 15-minute exercise and during 15-minute electrophysiology study.

Secondary Outcomes (1)

  • Non-invasive exercise-based tests correlate with electrophysiology study.

    The secondary outcome looks at how the Regional Restitution Instability Index (R2I2) and Peak ECG restitution slope (PERS) measurements during a 15-minute exercise compare with those taken during 15 minute Non-Invasive Programmed Stimulation (NIPS).

Study Arms (3)

Participants with ICD

Those that exercise 3 hours or more per week and/or have a physically active occupation (e.g military, fire service, landscaper, etc.) and have been identified as at risk of sudden cardiac death. Therefore have been implanted with an implantable defibrillator (ICD) for primary or secondary prevention.

Participants without heart device

Those that exercise 3 hours or more per week and/or have a physically active occupation (e.g military, fire service, landscaper, etc.) and do not have any heart condition. Therefore have not been implanted with any heart device.

Participants with Pacemaker

Those that exercise 3 hours or more per week and/or have a physically active occupation (e.g military, fire service, landscaper, etc.) and have not been identified as at risk of sudden cardiac death. Therefore do not have an implantable cardioverter defibrillator, but have been implanted with a cardiac pacemaker due to other conditions.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study population will be from a single tertiary care hospital (University Hospitals Leicester), and residents of United Kingdom

You may qualify if:

  • Age 18 and over.
  • Participates in regular physical activity for at least 3 hours or greater weekly.
  • Having Implantable cardioverter defibrillator insitu (cases).
  • Having a cardiac pacemaker (control).
  • Having no cardiac device (control).
  • Sufficient capacity and agreement to participate orally and signed written consent forms.
  • Understanding of written and spoken English language.

You may not qualify if:

  • Pregnancy, as detected by positive urine pregnancy test result.
  • Inability to comply with study protocols.
  • Any iatrogenic cardiac pathology (stents, CABG etc).
  • Unstable ventricular tachycardia (\>30 seconds).
  • Any unstable malignant arrhythmia.
  • Fever or presence of a clinically diagnosed febrile illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glenfield Hospital

Leicester, Leicestershire, LE3 9QP, United Kingdom

Location

Related Publications (2)

  • Nicolson WB, Smith MI, Vali Z, Samani NJ, Ng GA. Application of two novel electrical restitution-based ECG markers of ventricular arrhythmia to patients with nonischemic cardiomyopathy. Pacing Clin Electrophysiol. 2021 Feb;44(2):284-292. doi: 10.1111/pace.14143. Epub 2021 Jan 4.

    PMID: 33336815BACKGROUND
  • Ng GA, Mistry A, Li X, Schlindwein FS, Nicolson WB. LifeMap: towards the development of a new technology in sudden cardiac death risk stratification for clinical use. Europace. 2018 Sep 1;20(FI2):f162-f170. doi: 10.1093/europace/euy080.

    PMID: 29684162BACKGROUND

Related Links

MeSH Terms

Conditions

Death, Sudden, CardiacVentricular Fibrillation

Condition Hierarchy (Ancestors)

Heart ArrestHeart DiseasesCardiovascular DiseasesDeath, SuddenDeathPathologic ProcessesPathological Conditions, Signs and SymptomsArrhythmias, Cardiac

Study Officials

  • Ghulam André Ng, MBChB, MRCP, Ph.D, FRCP

    University of Leicester, Leicestershire, United Kingdom

    STUDY DIRECTOR
  • Ghulam André Ng, MBChB, MRCP, Ph.D, FRCP, FHEA

    University of Leicester, Leicestershire, United Kingdom

    PRINCIPAL INVESTIGATOR
  • Xin Li, PhD, MSc, BSc, FHEA

    University of Leicester, Leicestershire, United Kingdom

    PRINCIPAL INVESTIGATOR
  • Harshil Dhutia, MBBS, BSC, MRCP, CCDS, MD(RES)

    Glenfield Hospital, Leicester

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abdulmalik I Koya, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2025

First Posted

June 11, 2025

Study Start

June 1, 2025

Primary Completion

July 31, 2026

Study Completion

July 31, 2026

Last Updated

June 11, 2025

Record last verified: 2025-06

Locations